Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CLEARPOINT-NEURO-INC-30444363/news/ClearPoint-Neuro-Announces-First-Patient-Enrolled-in-Glioblastoma-Trial-Using-ClearPoint-Prism-Ne-42528112/?utm_source=whatsapp&utm_medium=social&utm_campaign=share